학술논문
3-Year Analysis of ZUMA-12: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) As First-Line Therapy in Patients with High-Risk Large B-Cell Lymphoma (LBCL)
Document Type
Journal
Author
Chavez, Julio C.; Dickinson, Michael; Munoz, Javier L.; Ulrickson, Matthew L.; Thieblemont, Catherine; Oluwole, Olalekan O.; Herrera, Alex F.; Ujjani, Chaitra S.; Lin, Yi; Riedell, Peter A.; Kekre, Natasha K.; de Vos, Sven; Lui, Christine; Wulff, Jacob; Williams, Chad M.; Peng, Weixin; Kloos, Ioana; Xu, Hairong; Neelapu, Sattva S.
Source
Subject
Language
English
ISSN
15280020